02/09/2026
The BioElectronics R&D team is seeking a physician or clinical researcher who is interested in collaborating on a vulvodynia-focused study to evaluate the effectiveness of RecoveryRx for treating vulvodynia pain.
RecoveryRx is a class II, USA FDA-cleared, drug-free, non-invasive, disposable, non-thermal shortwave therapy device that utilizes radio-frequency electromagnetic energy to modulate nerve activity. When used adjunctively, RecoveryRx has been found to reduce pain and the consumption of pain medication, including opioids. Our current published clinical data can be viewed at www.bielcorp.com
We’re working on a grant proposal for the National Vulvodynia Association and seek to partner with a medical professional who is excited about turning good clinical ideas into real-world evidence. This is an early-stage collaboration meaning no finalized protocol, no overwhelming paperwork (yet!), and no heavy upfront commitment. Just shared interest, clinical insight, and a desire to improve care for patients who truly need better options.
Please contact us at 301.874.4890 or email us at info@bielcorp.com